Prognostic value of baseline genetic features and newly identified TP53 mutations in advanced breast cancer

Approximately 30% of breast cancer (BC) patients suffer from disease relapse after definitive treatment. Monitoring BC at baseline and disease progression using comprehensive genomic profiling would facilitate the prediction of prognosis. We retrospectively studied 101 BC patients ultimately experie...

Full description

Bibliographic Details

Published in:	Molecular Oncology
Main Authors:	Lanxin Zhang, Siwen Sun, Xiaotian Zhao, Jingwen Liu, Yang Xu, Lingzhi Xu, Chen Song, Na Li, Jing Yu, Shanshan Zhao, Peiyao Yu, Fengqi Fang, Jiping Xie, Xuening Ji, Ruoying Yu, Qiuxiang Ou, Zuowei Zhao, Man Li
Format:	Article
Language:	English
Published:	Wiley 2022-10-01
Subjects:	advanced breast cancer baseline genetic features prognosis TP53 mutations
Online Access:	https://doi.org/10.1002/1878-0261.13297